247 related articles for article (PubMed ID: 27317025)
1. Xanthohumol inhibits the extracellular signal regulated kinase (ERK) signalling pathway and suppresses cell growth of lung adenocarcinoma cells.
Sławińska-Brych A; Zdzisińska B; Dmoszyńska-Graniczka M; Jeleniewicz W; Kurzepa J; Gagoś M; Stepulak A
Toxicology; 2016 May; 357-358():65-73. PubMed ID: 27317025
[TBL] [Abstract][Full Text] [Related]
2. Xanthohumol Impairs the PMA-Driven Invasive Behaviour of Lung Cancer Cell Line A549 and Exerts Anti-EMT Action.
Sławińska-Brych A; Mizerska-Kowalska M; Król SK; Stepulak A; Zdzisińska B
Cells; 2021 Jun; 10(6):. PubMed ID: 34204745
[TBL] [Abstract][Full Text] [Related]
3. Xanthohumol exhibits anti-myeloma activity in vitro through inhibition of cell proliferation, induction of apoptosis via the ERK and JNK-dependent mechanism, and suppression of sIL-6R and VEGF production.
Sławińska-Brych A; Zdzisińska B; Czerwonka A; Mizerska-Kowalska M; Dmoszyńska-Graniczka M; Stepulak A; Gagoś M
Biochim Biophys Acta Gen Subj; 2019 Nov; 1863(11):129408. PubMed ID: 31386885
[TBL] [Abstract][Full Text] [Related]
4. Xanthohumol chalcone acts as a powerful inhibitor of carcinogenesis in drug-resistant human colon carcinoma and these effects are mediated via G2/M phase cell cycle arrest, activation of apoptotic pathways, caspase activation and targeting Ras /MEK/ERK pathway.
Liu X; An LJ; Li Y; Wang Y; Zhao L; Lv X; Guo J; Song AL
J BUON; 2019; 24(6):2442-2447. PubMed ID: 31983118
[TBL] [Abstract][Full Text] [Related]
5. Xanthohumol inhibits cell cycle progression and proliferation of larynx cancer cells in vitro.
Sławińska-Brych A; Król SK; Dmoszyńska-Graniczka M; Zdzisińska B; Stepulak A; Gagoś M
Chem Biol Interact; 2015 Oct; 240():110-8. PubMed ID: 26297991
[TBL] [Abstract][Full Text] [Related]
6. p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.
Zheng F; Tang Q; Wu J; Zhao S; Liang Z; Li L; Wu W; Hann S
J Exp Clin Cancer Res; 2014 Apr; 33(1):36. PubMed ID: 24766860
[TBL] [Abstract][Full Text] [Related]
7. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer.
Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS
J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688
[TBL] [Abstract][Full Text] [Related]
8. The miR-204-3p-targeted IGFBP2 pathway is involved in xanthohumol-induced glioma cell apoptotic death.
Chen PH; Chang CK; Shih CM; Cheng CH; Lin CW; Lee CC; Liu AJ; Ho KH; Chen KC
Neuropharmacology; 2016 Nov; 110(Pt A):362-375. PubMed ID: 27487563
[TBL] [Abstract][Full Text] [Related]
9. An α-quaternary chiral latam derivative, YH-304 as a novel broad-spectrum anticancer agent.
Hwang SJ; Park HG; Park Y; Lee HJ
Int J Oncol; 2016 Dec; 49(6):2480-2486. PubMed ID: 27748805
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate.
Zhang X; Min KW; Wimalasena J; Baek SJ
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2051-60. PubMed ID: 22814742
[TBL] [Abstract][Full Text] [Related]
11. MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas.
Zhang X; Teng Y; Yang F; Wang M; Hong X; Ye LG; Gao YN; Chen GY
Oncol Rep; 2015 May; 33(5):2599-605. PubMed ID: 25738322
[TBL] [Abstract][Full Text] [Related]
12. Targeted elimination of senescent Ras-transformed cells by suppression of MEK/ERK pathway.
Kochetkova EY; Blinova GI; Bystrova OA; Martynova MG; Pospelov VA; Pospelova TV
Aging (Albany NY); 2017 Nov; 9(11):2352-2375. PubMed ID: 29140794
[TBL] [Abstract][Full Text] [Related]
13. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
14. Fucosterol exerts antiproliferative effects on human lung cancer cells by inducing apoptosis, cell cycle arrest and targeting of Raf/MEK/ERK signalling pathway.
Mao Z; Shen X; Dong P; Liu G; Pan S; Sun X; Hu H; Pan L; Huang J
Phytomedicine; 2019 Aug; 61():152809. PubMed ID: 31035050
[TBL] [Abstract][Full Text] [Related]
15. Xanthohumol induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI3K/Akt/mTOR-kinase in human gastric cancer cells.
Guo D; Zhang B; Liu S; Jin M
Biomed Pharmacother; 2018 Oct; 106():1300-1306. PubMed ID: 30119200
[TBL] [Abstract][Full Text] [Related]
16. A novel anticancer agent, SKLB70359, inhibits human hepatic carcinoma cells proliferation via G0/G1 cell cycle arrest and apoptosis induction.
Dai XY; Zeng XX; Peng F; Han YY; Lin HJ; Xu YZ; Zhou T; Xie G; Deng Y; Mao YQ; Yu LT; Yang L; Zhao YL
Cell Physiol Biochem; 2012; 29(1-2):281-90. PubMed ID: 22415097
[TBL] [Abstract][Full Text] [Related]
17. Xanthohumol targets the ERK1/2‑Fra1 signaling axis to reduce cyclin D1 expression and inhibit non‑small cell lung cancer.
Gao F; Li M; Zhou L; Liu W; Zuo H; Li W
Oncol Rep; 2020 Oct; 44(4):1365-1374. PubMed ID: 32945473
[TBL] [Abstract][Full Text] [Related]
18. Asperolide A, a marine-derived tetranorditerpenoid, induces G2/M arrest in human NCI-H460 lung carcinoma cells, is mediated by p53-p21 stabilization and modulated by Ras/Raf/MEK/ERK signaling pathway.
Lv C; Sun W; Sun H; Wei S; Chen R; Wang B; Huang C
Mar Drugs; 2013 Jan; 11(2):316-31. PubMed ID: 23434831
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase A inhibition facilitates the antitumor activity of xanthohumol, a valosin-containing protein inhibitor.
Shikata Y; Yoshimaru T; Komatsu M; Katoh H; Sato R; Kanagaki S; Okazaki Y; Toyokuni S; Tashiro E; Ishikawa S; Katagiri T; Imoto M
Cancer Sci; 2017 Apr; 108(4):785-794. PubMed ID: 28122154
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of ZD1839-induced G1-cell cycle arrest and apoptosis in human lung adenocarcinoma A549 cells.
Chang GC; Hsu SL; Tsai JR; Liang FP; Lin SY; Sheu GT; Chen CY
Biochem Pharmacol; 2004 Oct; 68(7):1453-64. PubMed ID: 15345335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
